Cencora, Inc.

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cencora, Inc. and other ETFs, options, and stocks.

About COR

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. 

CEO
Robert P. Mauch
CEORobert P. Mauch
Employees
51,000
Employees51,000
Headquarters
Conshohocken, Pennsylvania
HeadquartersConshohocken, Pennsylvania
Founded
1947
Founded1947
Employees
51,000
Employees51,000

COR Key Statistics

Market cap
64.49B
Market cap64.49B
Price-Earnings ratio
23.66
Price-Earnings ratio23.66
Dividend yield
0.76%
Dividend yield0.76%
Average volume
1.61M
Average volume1.61M
High today
$328.99
High today$328.99
Low today
$300.00
Low today$300.00
Open price
$324.04
Open price$324.04
Volume
1.41M
Volume1.41M
52 Week high
$377.54
52 Week high$377.54
52 Week low
$244.82
52 Week low$244.82

Stock Snapshot

As of today, Cencora, Inc.(COR) shares are valued at $320.46. The company's market cap stands at 64.49B, with a P/E ratio of 23.66 and a dividend yield of 0.76%.

As of 2026-08-09, Cencora, Inc.(COR) stock has fluctuated between $300.00 and $328.99. The current price stands at $320.46, placing the stock +6.8% above today's low and -2.6% off the high.

Cencora, Inc.(COR) shares are trading with a volume of 1.41M, against a daily average of 1.61M.

During the past year, Cencora, Inc.(COR) stock moved between $244.82 at its lowest and $377.54 at its peak.

During the past year, Cencora, Inc.(COR) stock moved between $244.82 at its lowest and $377.54 at its peak.

COR News

Simply Wall St 1d
The Bull Case For Cencora Could Change Following Raised EPS Outlook And Bigger Buybacks And Dividend

Cencora recently reported third-quarter 2026 results showing higher sales of US$84,754.84 million and net income of US$763.52 million, alongside amendments to i...

The Bull Case For Cencora Could Change Following Raised EPS Outlook And Bigger Buybacks And Dividend
TipRanks 3d
Cencora price target raised to $430 from $412 at UBS

UBS analyst Kevin Caliendo raised the firm’s price target on Cencora (COR) to $430 from $412 and keeps a Buy rating on the shares. Unlock powerful investing to...

Simply Wall St 3d
Cencora Stock Climbs As Margin Expansion Drives Profit Momentum

Cencora stock jumped 3.6% to US$317.22 after earnings, even though the headline result was all about profit pressure rather than a revenue surprise. The company...

Cencora Stock Climbs As Margin Expansion Drives Profit Momentum

Analyst ratings

78%

of 18 ratings
Buy
77.8%
Hold
22.2%
Sell
0%

More COR News

TipRanks 3d
Cencora Earnings Call Highlights Specialty-Driven Profit Surge

Cencora, Inc. ((COR)) has held its Q3 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock powerful investing tools with Ti...

Benzinga 4d
Cencora Sees Specialty Growth Continue While GLP-1 Mix Weighs on Margins

The pharmaceutical solutions organization reported sales of $84.754 billion, up 5.1% year-over-year, beating the consensus of $84.315 billion, driven by steady...

Cencora Sees Specialty Growth Continue While GLP-1 Mix Weighs on Margins
TipRanks 4d
Cencora Raises 2026 EPS Outlook After Strong Quarter

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

People also own

Based on the portfolios of people who own COR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.